The new Federal Trade Commission chairwoman, Edith Ramirez, has placed the healthcare industry at the top of priorities for the regulator at a meeting attended by antitrust enforcers from around the globe. The decision to focus on healthcare reflects two major cases currently in the hands of the US Supreme Court: the so-called pay-for-delay controversy, and a recent hospital merger in Georgia. The first is expected to see a resolution by July and may change the competition landscape of generic and brand name drug makers. Concerning the hospital merger in Georgia, the Federal Trade Commission recently moved to block a deal where Phoebe Putney Memorial Hospital bought Palmyra Medical Center. The acquisition was completed in 2011 and the case currently before the Supreme Court revolves around whether the local hospital authority, which allowed the merger, trumps federal antitrust law.
Featured News
Congress Is Debating How to Regulate Buy Now, Pay Later and States Aren’t Waiting
Mar 18, 2026 by
CPI
EU Moves to Rein in National Interference in Corporate Mergers
Mar 18, 2026 by
CPI
Germany Targets Fuel Price Spikes With New Daily Cap on Increases
Mar 17, 2026 by
CPI
Visa and Mastercard Win Right to Appeal UK Ruling on Interchange Fees
Mar 17, 2026 by
CPI
Spain’s Antitrust and Energy Watchdog to Release Blackout Report Without Blame
Mar 17, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece